Basic information Safety Supplier Related

(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid

Basic information Safety Supplier Related

(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Basic information

Product Name:
(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid
Synonyms:
  • (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid
  • 3beta-Hydroxy-24-methylene-8-lanosten-21-oic acid
  • Eburcoic acid
  • NSC 41969
  • Eburicoic acid 3β-Hydroxy-24-methylene-8-lanosten-21-oic acid
  • Lanost-8-en-21-oic acid, 3-hydroxy-24-methylene-, (3β)-
  • Eburicoicaci
  • Eburicoic acid 3β-Hydroxy-24-methylene-8-lanosten-21-oic acid
CAS:
560-66-7
MF:
C31H50O3
MW:
470.74
Product Categories:
  • Natural metabolites
Mol File:
560-66-7.mol
More
Less

(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Chemical Properties

Melting point:
283 °C
Boiling point:
572.6±50.0 °C(Predicted)
Density 
1.05±0.1 g/cm3(Predicted)
solubility 
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
form 
Powder
pka
4.65±0.10(Predicted)
More
Less

(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Usage And Synthesis

Uses

Eburicoic Acid can be useful in the study of constituents from fruiting bodies of Trametes cubensis and Trametes suaveolens in Vietnam and their anti-inflammatory bioactivity.

target

SOD | NO | TNF-α | NOS | COX | P450 (e.g. CYP17) | IL Receptor

(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acidSupplier

Chengdu Biopurify Phytochemicals Ltd.
Tel
+86-028-82633397 18982077548
Email
cwb1@biopurify.cn
Shanghai Winherb Medical Technology Co., Ltd.
Tel
400-186-5138 13341702378
Email
winherb@126.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Email
sales@reading-chemicals.com
ALB Technology Limited
Tel
702-983-3769
Email
sales@albtechnology.com
Wuhan ChemFaces Biochemical Co., Ltd.
Tel
18607101326 15172504745
Email
aileen@chemfaces.com
More
Less

(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid(560-66-7)Related Product Information